In the absence of Epstein-Barr virus infection, phorbol ester modulates apoptosis in cycloheximide-treated Burkitt's lymphoma (BJA-B) cells

International Journal of Experimental Pathology

Volumn 78, Issue 3, 1997, Pages 123-131

  Ishii, Hideaki ^a   Tamauchi, Hidekazu ^a   Gobé, Glenda C ^b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apoptosis; B cells; Cycloheximide; EBV; Phorbol ester; Protein kinase C

Indexed keywords

CYCLOHEXIMIDE; PHORBOL DIBUTYRATE; PROTEIN KINASE C; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CELL VIABILITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; LYMPHOMA CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION;

EID: 0030845976     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.1997.170350.x     Document Type: Article

References (40)

1. AMEISEN J.C. & CAPRON A. (1991) Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today 12, 102-105.
2. BLUMBERG P.M. (1988) Protein kinase C as the receptor for the phorbol ester tumor promoters: 6th Rhoads Memorial Award Lecture. Cancer Res. 48, 1-8.
3. BONNEFOY-BERARD N., GENESTIER L., FLACHER M. & REVILLARD J.P. (1994) The phosphoprotein phosphatase calcineurin controls calcium-dependent apoptosis in B cell lines. Eur. J. Immunol. 24, 325-329.
4. CARON-LESLIE L.A., EVANS R.B. & CIDLOWSKI J.A. (1994) Bcl-2 inhibits glucocorticoid-induced apoptosis but only partially blocks calcium ionophore or cycloheximide-regulated apoptosis in S49 cells. FASEB J. 8, 639-645.
5. CLEMENTS G.B., KLEIN G. & POVEY S. (1975) Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Int. J. Cancer 16, 125-133.
6. COLUMBANO A. (1995) Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J. Cell. Biochem. 58, 181-190.
7. DOLOETTI R. & BOIOCCHI M. (1996) Cellular and molecular bases of B-cell clonal expansion. Clin. Exp. Rheumatol 14, S3-S13.
8. EPSTEIN M.A. (1986) Infection and tumour induction. Nature 321, 653-654.
9. FALK M.H., HULTNER L., MILNER A., GREGORY C.D. & BORNKAMM G.W. (1993) Irradiated fibroblasts protect Burkitt lymphoma cells from apoptosis by a mechanism independent of bcl-2. Int. J. Cancer 55, 485-491.
10. FORBES I.J., ZALEWSKI P.D., GIANNAKIS C. & COWLED P.A. (1992) Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp. Cell Res. 198, 367-372.
11. GOBÉ G.C., BUTTYAN R., WYBURN K., ETHERIDGE M.R. & SMITH P.J. (1995) Clusterin expression and apoptosis in tissue remodelling associated with renal regeneration. Kidney Int. 47, 411-420.
12. GOBÉ G.C., BROWNING J., HOWARD T., WINTERFORD C., HOGG N. & CROSS R. (1997) Apoptosis occurs in endothelial cells of microvessels during microvascular (structural) rarefaction associated with hypertension. J. Struct. Biol. 118, 63-72.
13. GRASL-KRAUPP B., RUTTKAY-NEDECKY B., KOUDELKA H., BUKOWSKA K., BURSCH W. & SCHULTE-HERMANN, R. (1995) In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatol. 21, 1465-1468.
14. GREGORY C.D., DIVE C., HENDERSON S., SMITH C.A., WILLIAMS G.T., GORDON J. & RICKINSON A.B. (1991) Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature. 349, 612-614.
15. HAUSEN H. zur (1991) Viruses in human cancers. Science, 254, 1167-1173.
16. HENDERSON S., ROWE M., GREGORY C., CROOM-CARTER D., WANG F., LONGNECKER R., KIEFF E. & RICKINSON A. (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65, 1107-1115.
17. ISHII H., ETHERIDGE M. & GOBÉ G.C. (1995) Cycloheximide-induced apoptosis in Burkitt's lymphoma (BJA-B) cells with and without Epstein-Barr virus infection. Immunol. Cell Biol. 73, 463-468.
18. ISHII H. & GOBÉ G.C. (1993) Epstein-Barr virus infection is associated with increased apoptosis in untreated and phorbol ester-treated human lymphoma (AW-Ramos) cells. Biochem. Biophys. Res. Commun. 192, 1415-1423.
19. KAMESAKI H., ZWIEBEL J.A., REED J.C. & COSSMAN J. (1994) Role of bcl-2 and IL-5 in the regulation of anti-IgM-induced growth arrest and apoptosis in immature B cell lines. J. Immunol. 152, 3294-3305.
20. KERR J.F.R., GOBÉ G., WINTERFORD C. & HARMON B. (1995) Anatomical methods in cell death. Meth. Cell Biol. 46, 1-27.
21. KERR J.F.R., WINTERFORD C. & HARMON B.V. (1994) Apoptosis: Its significance in cancer and cancer therapy. Cancer 73, 2013-2026.
22. KIZAKI H., TADAKUMA T., OKADA C., MURAMATSU J. & ISHIMURA Y. (1989) Activation of a suicide process of thymocytes through DNA fragmentation by calcium ionophores and phorbol esters. J. Immunol 143, 1790-1794.
23. KRAFT A. & ANDERSON W.B. (1983) Phorbol esters increase the amount of Ca2+-, phospholipid-dependent protein kinase associated with plasma membrane. Nature, 301, 621-623.
24. MAGRATH I. (1990) The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 55, 133-270.
25. MARTIN S.J., LENNON S.V., BONHAM A.M. & COTTER T.G. (1990) Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J. Immunol. 145, 1859-1867.
26. MCCONKEY D.J., AGUILAR-SANTELISES M., HARTZELL P., ERIKSSON I., MELLSTEDT H., ORRENIUS S. & JONDAL M. (1991) Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. J. Immunol. 146, 1072-1076.
27. MCCONKEY D.J., HARTZELL P., JONDAL M. & ORRENIUS S. (1989) Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J. Biol. Chem. 264, 13399-13402.
28. MIHALIK R., KOPPER L. & BENCZUR M. (1995) Modulation of drug-induced apoptosis in a human B-lymphoma cell line (HT58). Immunology Letters. 48, 17-21.
29. NING Z. & MURPHY J.J. (1993) Calcium ionophore-induced apoptosis of human B cells is preceded by the induced expression of early response genes. Eur. J. Immunol. 23, 3369-3372.
30. PERREAULT J. & LEMIEUX R. (1993) Rapid apoptotic cell death of B-cell hybridomas in absence of gene expression. J. Cell. Physiol. 156, 286-293.
31. PONGRACZ J., JOHNSON G.D., CROCKER J., BURNETT D. & LORD J.M. (1994) The role of protein kinase C in myeloid cell apoptosis. Biochem. Soc. Trans. 22, 593-597.
32. RODRIGUEZ-TARDUCHY G. & LOPEZ-RIVAS A. (1989) Phorbol esters inhibit apoptosis in IL-2-dependent T lymphocytes. Biochem. Biophys. Res. Commun. 164, 1069-1075.
33. RUSNAK J.M. & LAZO J.S. (1996) Downregulation of protein kinase C suppresses induction of apoptosis in human prostatic carcinoma cells. Exp. Cell Res. 224, 189-199.
34. SCHWARTZ G.K., HAIMOVITZ-FHIEDMAN A., DHUPAR S.K., EHLEITER D., MASLAK P., LAI L., LOGANZO F., KELSEN D.P., FUKS Z. & ALBINO A.P. (1995) Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells. J. Natl. Cancer Inst. 87, 1394-1399.
35. SILINS S.L. & SCULLEY T.B. (1995) Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4. Int. J. Cancer. 60, 65-72.
36. VANDENBERGHE P.A. & CEUPPENS J.L. (1990) Flow cytometric measurement of cytoplasmic free calcium in human peripheral blood T lymphocytes with fluo-3, a new fluorescent calcium indicator. J. Immunol. Methods 127, 197-205.
37. WALKER N.I., HARMON B.V., GOBE G.C. & KERR J.F.R. (1988) Patterns of cell death. Meth. Achiev. exp. Pathol. 13, 18-54.
38. WOLF H., BOGEDAIN C. & SCHWARZMANN F. (1993) Epstein-Barr virus and its interaction with the host. Intervirology 35, 26-39.
39. WRIGHT S.C., ZHONG J. & LARRICK J.W. (1994) Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J. 8, 654-660.
40. ZHU W.-H & LOH T.-T. (1996) Differential effects of phorbol ester on apoptosis in HL-60 promyelocytic leukemia cells. Biochem. Pharmacol. 51, 1229-1236.